Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGIV-C in Cross Match Positive Living Donor Kidney Transplant Recipients
NCT00090194Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in end stage renal disease (ESRD), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2003; status: terminated.
02
Drugs
intravenous immunoglobulin G
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00090194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00090194.